VIJAYA Vijaya Diagnostic Centre Q3 FY26 results (Oct–Dec 2025) and concall
Vijaya Diagnostic Centre Limited reported a robust Q3 FY26, achieving its highest-ever quarterly revenue of ~INR 205 crores, a 21.4% YoY increase. This strong performance was driven by significant volume growth and balanced contributions from both radiology and pathology segments, alongside successful early breakeven of new hubs. The company also demonstrated strong profitability with an EBITDA margin of 41.9% and a 22.3% growth in PAT.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 21.3%, net profit up 22.9% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 183 | 169 | 173 | 188 | 202 +10% | 205 +21% |
| EBITDA | 76 | 67 | 69 | 74 | 82 +8% | 86 +28% |
| Net profit | 42 | 35 | 35 | 39 | 43 +2% | 43 +23% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
